TNFα antagonist therapy in axial spondyloarthritis: Can we do better?

Joint Bone Spine. 2016 May;83(3):247-9. doi: 10.1016/j.jbspin.2016.01.004. Epub 2016 Feb 10.
No abstract available

Keywords: Immunogenicity; Spondyloarthritis; TNFα antagonists; Treatment.

Publication types

  • Editorial

MeSH terms

  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use*
  • Humans
  • Spondylarthritis / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha